Skip to main content
Eben Rosenthal, MD, Otolaryngology (ENT), Nashville, TN, Vanderbilt University Medical Center

EbenLRosenthalMDFACS

Otolaryngology (ENT) Nashville, TN

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery

Guy Maness Professor and Chair Department of Otolaryngology Vanderbilt University Medical Center

Dr. Rosenthal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenthal's full profile

Already have an account?

  • Office

    Medical Center East, South Tower 37232
    1215 21st Ave South
    Nashville, TN 37232
    Phone+1 650-723-4000
  • Is this information wrong?

Summary

  • Eben L. Rosenthal is a surgeon-scientist who serves as the Guy Maness Professor and Chair of Otolaryngology. His primary interests are free flap surgery and molecular imaging. He continues to be clinically active as an oncologic and microvascular reconstructive surgeon. He was previously the John and Ann Doerr Medical Director of the Stanford Cancer Center from 2015-2021.

    Dr. Rosenthal has been continually funded by the NIH for the past 15 years to conduct bench to bedside translational studies in targeted therapy and molecular imaging. He has conducted over a dozen early phase clinical trials for diagnostic and therapeutic agents for the treatment of solid tumors. He is part of a multidisciplinary team of clinicians and basic scientists that perform preclinical animal studies including nonhuman primate IND-enabling studies, and first-in-human clinical trials. The team assesses near infrared fluorescent contrast agents for use in the operating room to make the cancer visible. Ongoing clinical trials include brain, lung, pancreas, skin and head and neck tumors. The lab also focuses on molecular imaging of fluorescently labeled therapeutic antibodies to measure cellular delivery of therapies to tumors and adjacent tissues.

    Dr. Rosenthal grew up in Ann Arbor, Michigan and went to Medical School and Residency at the University of Michigan after attending Haverford College for his undergraduate education

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Otolaryngology - Head and Neck Surgery, 1995 - 2000
  • University of Michigan Health System
    University of Michigan Health SystemInternship, Transitional Year, 1994 - 1995
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1994

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2000 - Present
  • TN State Medical License
    TN State Medical License 2021 - 2026
  • CA State Medical License
    CA State Medical License 2015 - 2025
  • AL State Medical License
    AL State Medical License Active through 2015
  • MI State Medical License
    MI State Medical License 1997 - 2002
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
  • Fellow (FACS) American College of Surgeons
  • America's Top Doctors Castle Connolly, 2012-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery  
    Eben Rosenthal, MD, Annals of Surgical Oncology

Lectures

  • Antibody-Based Imaging for Surgical Resections 
    Birmingham, AL - 10/27/2014

Press Mentions

  • Cutting-Edge Advances in Cancer Treatment Are Underway. Here Are 3 That Could Change Lives
    Cutting-Edge Advances in Cancer Treatment Are Underway. Here Are 3 That Could Change LivesApril 20th, 2023
  • Study Tracks Smell, Taste Loss Associated with COVID
    Study Tracks Smell, Taste Loss Associated with COVIDSeptember 23rd, 2021
  • Stanford’s Eben Rosenthal Named to Lead VUMC’s Otolaryngology-Head and Neck Surgery
    Stanford’s Eben Rosenthal Named to Lead VUMC’s Otolaryngology-Head and Neck SurgeryJune 11th, 2021

Grant Support

  • 8th Annual Conference On Head And Neck CancerNational Institute Of Dental &Craniofacial Research2012
  • CD147 As A Novel Target In Head And Neck CancerNational Cancer Institute2010–2012
  • Fluorescently Labeled Anti-Egfr To Guide Removal Of Lymph Node MetastasisNational Institute Of Dental &Craniofacial Research2009–2010
  • Tumor Stromal Interactions In Head And Neck CancerNational Cancer Institute2005–2009
  • Role Of Fibroblast-Derived MT1-MMP In Oral CancerNational Institute Of Dental &Craniofacial Research2005–2006

Professional Memberships

Hospital Affiliations